Beyond Estrogen Deficiency: Hormonal Influences, Diagnostic Challenges, and Integrated Management of Vulvar Dermatoses During Menopause
International Science Journal · 31.10.2026 · 4 (2)
DOI: 10.64784/381 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Science Journal, online erschienen am 31.10.2026. Verfasst von Javier Emanuel Camacho-Patiño und 7 weiteren Autor:innen.
Abstract (Originalsprache)
The menopausal transition is associated with significant endocrine, epithelial, and immunological changes that influence vulvar health and may complicate the recognition of inflammatory and autoimmune dermatological disorders. This narrative review aimed to analyze the relationship between menopausal hormonal alterations and vulvar dermatoses, emphasizing pathophysiological mechanisms, clinical manifestations, differential diagnosis, and evidence-based therapeutic strategies. A qualitative synthesis of 20 scientific publications was conducted, incorporating international clinical research, epidemiological investigations, reviews, and professional guidelines, including evidence from Latin America. The findings identified estrogen deficiency as an important contributor to epithelial fragility, reduced lubrication, altered vaginal microbiota, and genitourinary syndrome of menopause. However, these alterations frequently coexist with independent conditions, including lichen sclerosus, erosive lichen planus, contact dermatitis, lichen simplex chronicus, and genital psoriasis. Considerable overlap was observed in symptoms such as pruritus, burning, dryness, and dyspareunia, whereas characteristic morphological findings provided greater diagnostic differentiation. Epidemiological evidence demonstrated substantial variability in the reported prevalence of menopausal genitourinary symptoms, with relevant findings from a Brazilian population-based study. Therapeutic approaches differed according to the underlying condition, with local hormonal treatments and nonhormonal interventions primarily indicated for genitourinary syndrome of menopause, while topical anti-inflammatory agents remained central to the management of inflammatory dermatoses. The available evidence also highlighted uncertainties surrounding emerging therapeutic technologies and the limited representation of Latin American populations. In conclusion, vulvar disorders during the menopausal transition require comprehensive evaluation that distinguishes hormonal tissue changes from independent inflammatory diseases. An integrated dermatological, gynecological, and endocrinological approach is essential for accurate diagnosis, individualized treatment, and appropriate long-term clinical surveillance.
Zitieren
APA
Camacho-Patiño, J. E., León, G. A. D., Pérez, L. F. E., Chuquimarca, K. P. H., Riascos, E. R. C., Alvarado, M. P. A., Flores, C. J. I., & Conrado, J. J. O. (2026). Beyond Estrogen Deficiency: Hormonal Influences, Diagnostic Challenges, and Integrated Management of Vulvar Dermatoses During Menopause. International Science Journal, 4(2). https://doi.org/10.64784/381
Vancouver
Camacho-Patiño JE, León GAD, Pérez LFE, Chuquimarca KPH, Riascos ERC, Alvarado MPA, et al. Beyond Estrogen Deficiency: Hormonal Influences, Diagnostic Challenges, and Integrated Management of Vulvar Dermatoses During Menopause. International Science Journal. 2026;4(2). doi:10.64784/381
BibTeX
@article{CamachoPatio2026,
author = {Camacho-Patiño, Javier Emanuel and León, Guillermo Andres Díaz and Pérez, Luis Felipe Espinal and Chuquimarca, Katherine Paola Hidalgo and Riascos, Erika Romina Cuenca and Alvarado, Mireya Paola Almeida and Flores, Camilo José Izquierdo and Conrado, Javier José Ordoñez},
title = {Beyond Estrogen Deficiency: Hormonal Influences, Diagnostic Challenges, and Integrated Management of Vulvar Dermatoses During Menopause},
journal = {International Science Journal},
year = {2026},
volume = {4},
number = {2},
doi = {10.64784/381}
}
EUVIMED